Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
One reason for the longer development period: It can be difficult to run clinical trials with a second to market drug once therapy is available to treat an unmet need or rare disease. It’s becoming harder and harder to be second.
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.